nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—DRD2—nicotine dependence	0.765	1	CbGaD
Trifluoperazine—S100A4—cardiovascular system—nicotine dependence	0.00654	0.0923	CbGeAlD
Trifluoperazine—CALY—midbrain—nicotine dependence	0.00591	0.0835	CbGeAlD
Trifluoperazine—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.00563	0.0886	CcSEcCtD
Trifluoperazine—TNNC1—cardiovascular system—nicotine dependence	0.0055	0.0777	CbGeAlD
Trifluoperazine—S100A4—midbrain—nicotine dependence	0.00511	0.0721	CbGeAlD
Trifluoperazine—EBPL—brain—nicotine dependence	0.00406	0.0574	CbGeAlD
Trifluoperazine—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00388	0.061	CcSEcCtD
Trifluoperazine—CALY—brain—nicotine dependence	0.00372	0.0525	CbGeAlD
Trifluoperazine—Mydriasis—Varenicline—nicotine dependence	0.00366	0.0576	CcSEcCtD
Trifluoperazine—Glycosuria—Varenicline—nicotine dependence	0.00361	0.0567	CcSEcCtD
Trifluoperazine—S100A4—brain—nicotine dependence	0.00321	0.0453	CbGeAlD
Trifluoperazine—CHRM2—cardiovascular system—nicotine dependence	0.00236	0.0333	CbGeAlD
Trifluoperazine—Eczema—Varenicline—nicotine dependence	0.00236	0.0371	CcSEcCtD
Trifluoperazine—Increased appetite—Varenicline—nicotine dependence	0.00226	0.0355	CcSEcCtD
Trifluoperazine—Hypoglycaemia—Varenicline—nicotine dependence	0.00217	0.0342	CcSEcCtD
Trifluoperazine—Urinary retention—Varenicline—nicotine dependence	0.00202	0.0317	CcSEcCtD
Trifluoperazine—HTR6—brain—nicotine dependence	0.00193	0.0273	CbGeAlD
Trifluoperazine—HTR1A—cardiovascular system—nicotine dependence	0.00191	0.027	CbGeAlD
Trifluoperazine—CALM2—cardiovascular system—nicotine dependence	0.00188	0.0266	CbGeAlD
Trifluoperazine—CALM1—cardiovascular system—nicotine dependence	0.00187	0.0264	CbGeAlD
Trifluoperazine—CALM3—midbrain—nicotine dependence	0.00187	0.0264	CbGeAlD
Trifluoperazine—Dysphagia—Varenicline—nicotine dependence	0.00183	0.0288	CcSEcCtD
Trifluoperazine—Asthma—Varenicline—nicotine dependence	0.00183	0.0288	CcSEcCtD
Trifluoperazine—HTR2C—midbrain—nicotine dependence	0.00178	0.0251	CbGeAlD
Trifluoperazine—ADRA1A—cardiovascular system—nicotine dependence	0.00177	0.0249	CbGeAlD
Trifluoperazine—Erectile dysfunction—Varenicline—nicotine dependence	0.00169	0.0266	CcSEcCtD
Trifluoperazine—Photosensitivity reaction—Varenicline—nicotine dependence	0.00167	0.0263	CcSEcCtD
Trifluoperazine—SIGMAR1—midbrain—nicotine dependence	0.00167	0.0236	CbGeAlD
Trifluoperazine—Weight increased—Varenicline—nicotine dependence	0.00167	0.0262	CcSEcCtD
Trifluoperazine—Hyperglycaemia—Varenicline—nicotine dependence	0.00165	0.026	CcSEcCtD
Trifluoperazine—HTR1A—midbrain—nicotine dependence	0.0015	0.0211	CbGeAlD
Trifluoperazine—CALM2—midbrain—nicotine dependence	0.00147	0.0207	CbGeAlD
Trifluoperazine—CALM1—midbrain—nicotine dependence	0.00146	0.0207	CbGeAlD
Trifluoperazine—Oedema peripheral—Varenicline—nicotine dependence	0.00144	0.0227	CcSEcCtD
Trifluoperazine—DRD2—midbrain—nicotine dependence	0.00135	0.0191	CbGeAlD
Trifluoperazine—Erythema—Varenicline—nicotine dependence	0.00128	0.0201	CcSEcCtD
Trifluoperazine—Muscle spasms—Varenicline—nicotine dependence	0.00123	0.0193	CcSEcCtD
Trifluoperazine—Vision blurred—Varenicline—nicotine dependence	0.0012	0.0189	CcSEcCtD
Trifluoperazine—Tremor—Varenicline—nicotine dependence	0.0012	0.0188	CcSEcCtD
Trifluoperazine—CALM3—brain—nicotine dependence	0.00118	0.0166	CbGeAlD
Trifluoperazine—Agitation—Varenicline—nicotine dependence	0.00117	0.0185	CcSEcCtD
Trifluoperazine—Angioedema—Varenicline—nicotine dependence	0.00117	0.0184	CcSEcCtD
Trifluoperazine—CHRM2—brain—nicotine dependence	0.00116	0.0163	CbGeAlD
Trifluoperazine—HTR2A—cardiovascular system—nicotine dependence	0.00114	0.0161	CbGeAlD
Trifluoperazine—HTR2C—brain—nicotine dependence	0.00112	0.0158	CbGeAlD
Trifluoperazine—Cough—Varenicline—nicotine dependence	0.00111	0.0175	CcSEcCtD
Trifluoperazine—Convulsion—Varenicline—nicotine dependence	0.00111	0.0174	CcSEcCtD
Trifluoperazine—Dry mouth—Varenicline—nicotine dependence	0.00106	0.0167	CcSEcCtD
Trifluoperazine—SIGMAR1—brain—nicotine dependence	0.00105	0.0148	CbGeAlD
Trifluoperazine—Skin disorder—Varenicline—nicotine dependence	0.00101	0.0159	CcSEcCtD
Trifluoperazine—Anorexia—Varenicline—nicotine dependence	0.000993	0.0156	CcSEcCtD
Trifluoperazine—Hypotension—Varenicline—nicotine dependence	0.000974	0.0153	CcSEcCtD
Trifluoperazine—Insomnia—Varenicline—nicotine dependence	0.000943	0.0148	CcSEcCtD
Trifluoperazine—HTR1A—brain—nicotine dependence	0.00094	0.0133	CbGeAlD
Trifluoperazine—Dyspnoea—Varenicline—nicotine dependence	0.000929	0.0146	CcSEcCtD
Trifluoperazine—Somnolence—Varenicline—nicotine dependence	0.000926	0.0146	CcSEcCtD
Trifluoperazine—CALM2—brain—nicotine dependence	0.000923	0.013	CbGeAlD
Trifluoperazine—CALM1—brain—nicotine dependence	0.000919	0.013	CbGeAlD
Trifluoperazine—Decreased appetite—Varenicline—nicotine dependence	0.000906	0.0143	CcSEcCtD
Trifluoperazine—Fatigue—Varenicline—nicotine dependence	0.000898	0.0141	CcSEcCtD
Trifluoperazine—Flupentixol—DRD2—nicotine dependence	0.000898	0.104	CrCbGaD
Trifluoperazine—HTR2A—midbrain—nicotine dependence	0.000891	0.0126	CbGeAlD
Trifluoperazine—Constipation—Varenicline—nicotine dependence	0.000891	0.014	CcSEcCtD
Trifluoperazine—ADRA1A—brain—nicotine dependence	0.000866	0.0122	CbGeAlD
Trifluoperazine—DRD2—brain—nicotine dependence	0.000849	0.012	CbGeAlD
Trifluoperazine—Urticaria—Varenicline—nicotine dependence	0.000828	0.013	CcSEcCtD
Trifluoperazine—Body temperature increased—Varenicline—nicotine dependence	0.000824	0.013	CcSEcCtD
Trifluoperazine—Acetophenazine—DRD2—nicotine dependence	0.000797	0.0925	CrCbGaD
Trifluoperazine—Hypersensitivity—Varenicline—nicotine dependence	0.000768	0.0121	CcSEcCtD
Trifluoperazine—ABCB1—cardiovascular system—nicotine dependence	0.000748	0.0106	CbGeAlD
Trifluoperazine—Asthenia—Varenicline—nicotine dependence	0.000748	0.0118	CcSEcCtD
Trifluoperazine—Pruritus—Varenicline—nicotine dependence	0.000737	0.0116	CcSEcCtD
Trifluoperazine—Dizziness—Varenicline—nicotine dependence	0.000689	0.0108	CcSEcCtD
Trifluoperazine—HRH1—brain—nicotine dependence	0.00067	0.00946	CbGeAlD
Trifluoperazine—Rash—Varenicline—nicotine dependence	0.000657	0.0103	CcSEcCtD
Trifluoperazine—Dermatitis—Varenicline—nicotine dependence	0.000656	0.0103	CcSEcCtD
Trifluoperazine—Headache—Varenicline—nicotine dependence	0.000653	0.0103	CcSEcCtD
Trifluoperazine—Nausea—Varenicline—nicotine dependence	0.000619	0.00974	CcSEcCtD
Trifluoperazine—ABCB1—midbrain—nicotine dependence	0.000584	0.00824	CbGeAlD
Trifluoperazine—HTR2A—brain—nicotine dependence	0.00056	0.0079	CbGeAlD
Trifluoperazine—Zuclopenthixol—DRD2—nicotine dependence	0.000504	0.0585	CrCbGaD
Trifluoperazine—Triflupromazine—DRD2—nicotine dependence	0.000489	0.0567	CrCbGaD
Trifluoperazine—Acepromazine—DRD2—nicotine dependence	0.000452	0.0525	CrCbGaD
Trifluoperazine—Thioproperazine—DRD2—nicotine dependence	0.000442	0.0513	CrCbGaD
Trifluoperazine—Thiothixene—DRD2—nicotine dependence	0.000435	0.0505	CrCbGaD
Trifluoperazine—Pipotiazine—DRD2—nicotine dependence	0.000435	0.0505	CrCbGaD
Trifluoperazine—Mesoridazine—DRD2—nicotine dependence	0.000429	0.0498	CrCbGaD
Trifluoperazine—Prochlorperazine—DRD2—nicotine dependence	0.000416	0.0482	CrCbGaD
Trifluoperazine—Fluphenazine—DRD2—nicotine dependence	0.000376	0.0436	CrCbGaD
Trifluoperazine—ABCB1—brain—nicotine dependence	0.000367	0.00518	CbGeAlD
Trifluoperazine—Propiomazine—DRD2—nicotine dependence	0.000361	0.042	CrCbGaD
Trifluoperazine—Thioridazine—DRD2—nicotine dependence	0.000324	0.0376	CrCbGaD
Trifluoperazine—Methotrimeprazine—DRD2—nicotine dependence	0.000309	0.0359	CrCbGaD
Trifluoperazine—Promethazine—DRD2—nicotine dependence	0.000304	0.0353	CrCbGaD
Trifluoperazine—Loxapine—DRD2—nicotine dependence	0.000299	0.0347	CrCbGaD
Trifluoperazine—Perphenazine—DRD2—nicotine dependence	0.000297	0.0345	CrCbGaD
Trifluoperazine—Quetiapine—DRD2—nicotine dependence	0.000291	0.0338	CrCbGaD
Trifluoperazine—Promazine—DRD2—nicotine dependence	0.000268	0.0311	CrCbGaD
Trifluoperazine—Clozapine—DRD2—nicotine dependence	0.000251	0.0291	CrCbGaD
Trifluoperazine—CALM3—Neuronal System—GABRA4—nicotine dependence	0.000241	0.00262	CbGpPWpGaD
Trifluoperazine—Chlorpromazine—DRD2—nicotine dependence	0.000236	0.0274	CrCbGaD
Trifluoperazine—CALM2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000235	0.00256	CbGpPWpGaD
Trifluoperazine—CALM1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000235	0.00256	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000234	0.00255	CbGpPWpGaD
Trifluoperazine—CALM2—Neuronal System—GABRA4—nicotine dependence	0.000233	0.00254	CbGpPWpGaD
Trifluoperazine—CALM1—Neuronal System—GABRA4—nicotine dependence	0.000233	0.00254	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000233	0.00253	CbGpPWpGaD
Trifluoperazine—CALM3—Neuronal System—CHRNB4—nicotine dependence	0.000231	0.00251	CbGpPWpGaD
Trifluoperazine—HTR6—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000229	0.00249	CbGpPWpGaD
Trifluoperazine—CALM3—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000229	0.00249	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000228	0.00248	CbGpPWpGaD
Trifluoperazine—CALM2—Neuronal System—CHRNB4—nicotine dependence	0.000224	0.00243	CbGpPWpGaD
Trifluoperazine—CALM1—Neuronal System—CHRNB4—nicotine dependence	0.000224	0.00243	CbGpPWpGaD
Trifluoperazine—DRD2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000222	0.00241	CbGpPWpGaD
Trifluoperazine—CALM1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000221	0.00241	CbGpPWpGaD
Trifluoperazine—CALM2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000221	0.00241	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR downstream signaling—FGD1—nicotine dependence	0.000217	0.00236	CbGpPWpGaD
Trifluoperazine—CALM3—Neuronal System—CHRNA5—nicotine dependence	0.000215	0.00234	CbGpPWpGaD
Trifluoperazine—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000215	0.00234	CbGpPWpGaD
Trifluoperazine—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000214	0.00233	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000212	0.0023	CbGpPWpGaD
Trifluoperazine—CALM2—Neuronal System—CHRNA5—nicotine dependence	0.000208	0.00226	CbGpPWpGaD
Trifluoperazine—CALM1—Neuronal System—CHRNA5—nicotine dependence	0.000208	0.00226	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR ligand binding—OPRM1—nicotine dependence	0.000206	0.00224	CbGpPWpGaD
Trifluoperazine—DRD2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000206	0.00224	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000205	0.00223	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000204	0.00222	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000202	0.0022	CbGpPWpGaD
Trifluoperazine—HRH1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000202	0.0022	CbGpPWpGaD
Trifluoperazine—CALM3—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000201	0.00219	CbGpPWpGaD
Trifluoperazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000201	0.00218	CbGpPWpGaD
Trifluoperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.0002	0.00217	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000199	0.00216	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000198	0.00215	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—FGD1—nicotine dependence	0.000197	0.00214	CbGpPWpGaD
Trifluoperazine—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000196	0.00213	CbGpPWpGaD
Trifluoperazine—CALM1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000195	0.00212	CbGpPWpGaD
Trifluoperazine—CALM2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000195	0.00212	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000186	0.00202	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.000185	0.00201	CbGpPWpGaD
Trifluoperazine—CALM3—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000183	0.00199	CbGpPWpGaD
Trifluoperazine—HTR1A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000182	0.00198	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00018	0.00196	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000177	0.00192	CbGpPWpGaD
Trifluoperazine—CALM2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000177	0.00192	CbGpPWpGaD
Trifluoperazine—CALM1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000177	0.00192	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000177	0.00192	CbGpPWpGaD
Trifluoperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000176	0.00192	CbGpPWpGaD
Trifluoperazine—CALM3—Neuronal System—CHRNA3—nicotine dependence	0.000175	0.00191	CbGpPWpGaD
Trifluoperazine—UGT1A4—Metabolism—CYP2A7—nicotine dependence	0.000175	0.0019	CbGpPWpGaD
Trifluoperazine—XDH—Metabolism—CYP2A7—nicotine dependence	0.000175	0.0019	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000174	0.00189	CbGpPWpGaD
Trifluoperazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000173	0.00189	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000173	0.00188	CbGpPWpGaD
Trifluoperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000173	0.00188	CbGpPWpGaD
Trifluoperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00017	0.00185	CbGpPWpGaD
Trifluoperazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00017	0.00185	CbGpPWpGaD
Trifluoperazine—CALM1—Neuronal System—CHRNA3—nicotine dependence	0.00017	0.00184	CbGpPWpGaD
Trifluoperazine—CALM2—Neuronal System—CHRNA3—nicotine dependence	0.00017	0.00184	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000169	0.00184	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000168	0.00183	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000163	0.00178	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000161	0.00175	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000161	0.00175	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00016	0.00174	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.00016	0.00174	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000158	0.00172	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000157	0.00171	CbGpPWpGaD
Trifluoperazine—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.000155	0.00168	CbGpPWpGaD
Trifluoperazine—CALM3—Neuronal System—CHRNB2—nicotine dependence	0.000154	0.00168	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000153	0.00166	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000152	0.00165	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR ligand binding—DRD2—nicotine dependence	0.000149	0.00162	CbGpPWpGaD
Trifluoperazine—CALM1—Neuronal System—CHRNB2—nicotine dependence	0.000149	0.00162	CbGpPWpGaD
Trifluoperazine—CALM2—Neuronal System—CHRNB2—nicotine dependence	0.000149	0.00162	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—TAS2R16—nicotine dependence	0.000148	0.00161	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000146	0.00159	CbGpPWpGaD
Trifluoperazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000146	0.00159	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.000146	0.00159	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000145	0.00158	CbGpPWpGaD
Trifluoperazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000145	0.00158	CbGpPWpGaD
Trifluoperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000144	0.00157	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000144	0.00156	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000143	0.00156	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000141	0.00153	CbGpPWpGaD
Trifluoperazine—CALM3—Neuronal System—CHRNA4—nicotine dependence	0.00014	0.00152	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000139	0.00151	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—FGD1—nicotine dependence	0.000139	0.00151	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.000136	0.00148	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000136	0.00148	CbGpPWpGaD
Trifluoperazine—CALM2—Neuronal System—CHRNA4—nicotine dependence	0.000136	0.00147	CbGpPWpGaD
Trifluoperazine—CALM1—Neuronal System—CHRNA4—nicotine dependence	0.000136	0.00147	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000134	0.00146	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—TAS2R16—nicotine dependence	0.000133	0.00145	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000132	0.00144	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR ligand binding—OPRM1—nicotine dependence	0.000132	0.00143	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.00013	0.00141	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000129	0.00141	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000129	0.0014	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000129	0.0014	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000128	0.00139	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.000126	0.00137	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—FGD1—nicotine dependence	0.000126	0.00137	CbGpPWpGaD
Trifluoperazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000125	0.00136	CbGpPWpGaD
Trifluoperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000125	0.00136	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.000124	0.00135	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.000123	0.00134	CbGpPWpGaD
Trifluoperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000123	0.00134	CbGpPWpGaD
Trifluoperazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000123	0.00133	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR downstream signaling—OPRM1—nicotine dependence	0.000117	0.00127	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—FGD1—nicotine dependence	0.000117	0.00127	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	0.00011	0.0012	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	0.00011	0.0012	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	0.00011	0.00119	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	0.000109	0.00119	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—OPRM1—nicotine dependence	0.000106	0.00115	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—FGD1—nicotine dependence	0.000105	0.00114	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—AKR1B10—nicotine dependence	0.000103	0.00112	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—WASF2—nicotine dependence	0.000102	0.00111	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—FGD1—nicotine dependence	0.000101	0.0011	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—FGD1—nicotine dependence	0.000101	0.0011	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—WASF2—nicotine dependence	9.89e-05	0.00107	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—WASF2—nicotine dependence	9.89e-05	0.00107	CbGpPWpGaD
Trifluoperazine—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	9.83e-05	0.00107	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—WASF1—nicotine dependence	9.8e-05	0.00107	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	9.65e-05	0.00105	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	9.55e-05	0.00104	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR ligand binding—DRD2—nicotine dependence	9.53e-05	0.00104	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	9.49e-05	0.00103	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—WASF1—nicotine dependence	9.48e-05	0.00103	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—WASF1—nicotine dependence	9.48e-05	0.00103	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	9.47e-05	0.00103	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	9.37e-05	0.00102	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	9.35e-05	0.00102	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	9.32e-05	0.00101	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	9.3e-05	0.00101	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	8.64e-05	0.000939	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—FGD1—nicotine dependence	8.62e-05	0.000938	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	8.59e-05	0.000934	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—FGD1—nicotine dependence	8.58e-05	0.000933	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR downstream signaling—DRD2—nicotine dependence	8.44e-05	0.000917	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—TAS2R16—nicotine dependence	7.88e-05	0.000857	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	7.84e-05	0.000853	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	7.8e-05	0.000848	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—AKR1B10—nicotine dependence	7.8e-05	0.000848	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—DRD2—nicotine dependence	7.66e-05	0.000833	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—TAS2R16—nicotine dependence	7.62e-05	0.000829	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—TAS2R16—nicotine dependence	7.62e-05	0.000829	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	7.62e-05	0.000828	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	7.58e-05	0.000824	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	7.58e-05	0.000824	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—FGD1—nicotine dependence	7.57e-05	0.000823	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—AKR1B10—nicotine dependence	7.55e-05	0.00082	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—AKR1B10—nicotine dependence	7.55e-05	0.00082	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	7.46e-05	0.000811	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—FGD1—nicotine dependence	7.45e-05	0.00081	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	7.45e-05	0.000809	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—FGD1—nicotine dependence	7.43e-05	0.000808	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	7.33e-05	0.000796	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—FGD1—nicotine dependence	7.32e-05	0.000795	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	7.31e-05	0.000794	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	7.3e-05	0.000793	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—WASF2—nicotine dependence	7.25e-05	0.000788	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—WASF1—nicotine dependence	6.95e-05	0.000756	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	6.89e-05	0.000749	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	6.78e-05	0.000737	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	6.76e-05	0.000735	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	6.69e-05	0.000727	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	6.65e-05	0.000723	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	6.63e-05	0.000721	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	6.58e-05	0.000716	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	6.57e-05	0.000714	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	6.46e-05	0.000703	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	6.44e-05	0.000701	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—OPRM1—nicotine dependence	6.26e-05	0.00068	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	6.24e-05	0.000679	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	6.21e-05	0.000675	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—FGD1—nicotine dependence	6.18e-05	0.000672	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—CYP2A7—nicotine dependence	6.07e-05	0.00066	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—FGD1—nicotine dependence	5.98e-05	0.00065	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—FGD1—nicotine dependence	5.98e-05	0.00065	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—WASF2—nicotine dependence	5.95e-05	0.000647	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—CYP2A7—nicotine dependence	5.88e-05	0.000639	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—CYP2A7—nicotine dependence	5.88e-05	0.000639	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—WASF2—nicotine dependence	5.76e-05	0.000626	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—WASF2—nicotine dependence	5.76e-05	0.000626	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—WASF1—nicotine dependence	5.71e-05	0.000621	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	5.67e-05	0.000616	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	5.64e-05	0.000613	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—OPRM1—nicotine dependence	5.62e-05	0.000612	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—WASF1—nicotine dependence	5.52e-05	0.0006	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—WASF1—nicotine dependence	5.52e-05	0.0006	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—AKR1B10—nicotine dependence	5.46e-05	0.000594	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—OPRM1—nicotine dependence	5.44e-05	0.000592	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—OPRM1—nicotine dependence	5.44e-05	0.000592	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	5.39e-05	0.000586	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	5.38e-05	0.000585	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—WASF2—nicotine dependence	5.37e-05	0.000584	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—WASF2—nicotine dependence	5.34e-05	0.000581	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	5.3e-05	0.000576	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—AKR1B10—nicotine dependence	5.28e-05	0.000575	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—AKR1B10—nicotine dependence	5.28e-05	0.000575	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	5.28e-05	0.000574	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—WASF1—nicotine dependence	5.15e-05	0.000559	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—WASF1—nicotine dependence	5.12e-05	0.000557	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	4.9e-05	0.000533	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—DRD2—nicotine dependence	4.89e-05	0.000531	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	4.81e-05	0.000523	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	4.8e-05	0.000521	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—WASF2—nicotine dependence	4.71e-05	0.000512	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—WASF2—nicotine dependence	4.64e-05	0.000504	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	4.63e-05	0.000504	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—WASF2—nicotine dependence	4.63e-05	0.000503	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	4.61e-05	0.000501	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—CYP2A7—nicotine dependence	4.6e-05	0.0005	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—WASF2—nicotine dependence	4.55e-05	0.000495	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	4.54e-05	0.000494	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—DRD2—nicotine dependence	4.53e-05	0.000492	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—WASF1—nicotine dependence	4.52e-05	0.000491	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—WASF1—nicotine dependence	4.45e-05	0.000483	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—WASF1—nicotine dependence	4.44e-05	0.000482	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—WASF1—nicotine dependence	4.36e-05	0.000475	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	4.35e-05	0.000473	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—OPRM1—nicotine dependence	4.07e-05	0.000442	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—DRD2—nicotine dependence	4.07e-05	0.000442	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	4e-05	0.000435	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—OPRM1—nicotine dependence	3.99e-05	0.000434	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—DRD2—nicotine dependence	3.93e-05	0.000428	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—DRD2—nicotine dependence	3.93e-05	0.000428	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	3.93e-05	0.000427	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	3.92e-05	0.000426	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—WASF2—nicotine dependence	3.85e-05	0.000418	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—WASF2—nicotine dependence	3.72e-05	0.000405	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—WASF2—nicotine dependence	3.72e-05	0.000405	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—WASF1—nicotine dependence	3.69e-05	0.000401	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—CYP2A7—nicotine dependence	3.67e-05	0.0004	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—WASF1—nicotine dependence	3.57e-05	0.000388	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—WASF1—nicotine dependence	3.57e-05	0.000388	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—DRD2—nicotine dependence	3.35e-05	0.000364	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—DRD2—nicotine dependence	3.33e-05	0.000362	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—OPRM1—nicotine dependence	3.32e-05	0.000361	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—OPRM1—nicotine dependence	3.21e-05	0.000349	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—OPRM1—nicotine dependence	3.21e-05	0.000349	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—DRD2—nicotine dependence	2.89e-05	0.000315	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—DRD2—nicotine dependence	2.89e-05	0.000314	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—DRD2—nicotine dependence	2.84e-05	0.000309	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	2.83e-05	0.000308	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—DRD2—nicotine dependence	2.4e-05	0.000261	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—DRD2—nicotine dependence	2.32e-05	0.000253	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—DRD2—nicotine dependence	2.32e-05	0.000253	CbGpPWpGaD
